Ensysce Biosciences, Inc.

NasdaqCM:ENSC Stock Report

Market Cap: US$4.7m

Ensysce Biosciences Future Growth

Future criteria checks 5/6

Ensysce Biosciences is forecast to grow earnings and revenue by 73.6% and 95.6% per annum respectively while EPS is expected to grow by 78.9% per annum.

Key information

73.6%

Earnings growth rate

78.9%

EPS growth rate

Biotechs earnings growth20.7%
Revenue growth rate95.6%
Future return on equityn/a
Analyst coverage

Low

Last updated21 Mar 2024

Recent future growth updates

Recent updates

Ensysce Biosciences secures $8M convertible note financing

Jul 01

Ensysce Biosciences: Developing New Class Of Tamper-Proof Powerful Opioids

Dec 18

Earnings and Revenue Growth Forecasts

NasdaqCM:ENSC - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20266029N/AN/A2
12/31/202514-11N/AN/A2
12/31/20242-17N/AN/A2
12/31/20232-11-11-11N/A
9/30/20233-13-12-12N/A
6/30/20233-20-17-17N/A
3/31/20233-26-18-18N/A
12/31/20223-25-18-18N/A
9/30/20223-30-18-18N/A
6/30/20224-38-15-15N/A
3/31/20224-31-11-11N/A
12/31/20214-30-8-8N/A
9/30/20212-19-5-5N/A
6/30/202120-1-1N/A
3/31/202130-1-1N/A
12/31/202040-1-1N/A
12/31/20192-10-1-1N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ENSC is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.3%).

Earnings vs Market: ENSC is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: ENSC is expected to become profitable in the next 3 years.

Revenue vs Market: ENSC's revenue (95.6% per year) is forecast to grow faster than the US market (8% per year).

High Growth Revenue: ENSC's revenue (95.6% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if ENSC's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.